Paper32104016
Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates.
Guo Q and 8 others. Infect Drug Resist, 2020. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates. Papers, record 32104016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32104016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23598956 | The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. | Eur Respir J | 2013 | https://conductscience.org/library/papers/23598956 | PubMed |
| 2 | 27495169 | Functional characterization of the Mycobacterium abscessus genome coupled with condition specific transcriptomics reveals conserved molecular strategies for host adaptation and persistence. | BMC Genomics | 2016 | https://conductscience.org/library/papers/27495169 | PubMed |
| 3 | 15215089 | Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15215089 | PubMed |
| 4 | 29483126 | The Clarithromycin Susceptibility Genotype Affects the Treatment Outcome of Patients with Mycobacterium abscessus Lung Disease. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29483126 | PubMed |
| 5 | 28959242 | Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28959242 | PubMed |
| 6 | 30539658 | Mycobacterium tuberculosis Rv1473 is a novel macrolides ABC Efflux Pump regulated by WhiB7. | Future Microbiol | 2019 | https://conductscience.org/library/papers/30539658 | PubMed |
| 7 | 31430699 | In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus. | Tuberculosis (Edinb) | 2019 | https://conductscience.org/library/papers/31430699 | PubMed |
| 8 | 22751536 | The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22751536 | PubMed |
| 9 | 30478161 | Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30478161 | PubMed |
| 10 | 31221809 | Non-tuberculous mycobacterial pulmonary disease. | Eur Respir J | 2019 | https://conductscience.org/library/papers/31221809 | PubMed |
| 11 | 17426813 | Antibiotic stress, genetic response and altered permeability of E. coli. | PLoS One | 2007 | https://conductscience.org/library/papers/17426813 | PubMed |
| 12 | 29460734 | Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions1. | Emerg Infect Dis | 2018 | https://conductscience.org/library/papers/29460734 | PubMed |
| 13 | 22290346 | Mycobacterium abscessus: a new antibiotic nightmare. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22290346 | PubMed |
| 14 | 29101040 | Rv2477c is an antibiotic-sensitive manganese-dependent ABC-F ATPase in Mycobacterium tuberculosis. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29101040 | PubMed |
| 15 | 22493700 | Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. | PLoS One | 2012 | https://conductscience.org/library/papers/22493700 | PubMed |
| 16 | 31507579 | Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31507579 | PubMed |
| 17 | 17277290 | An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17277290 | PubMed |
| 18 | 30689764 | Mycobacterium abscessus and Antibiotic Resistance: Same As It Ever Was. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/30689764 | PubMed |
| 19 | 19564371 | Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19564371 | PubMed |
| 20 | 27846606 | Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. | Science | 2016 | https://conductscience.org/library/papers/27846606 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974473 | Antimicrobial Therapy, Disinfection, Resistance Mechanisms, and Microbiota Interactions in Nontuberculous Mycobacteria: Current Evidence and Emerging Perspectives. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42974473 | PubMed |
| 42935758 | Advances in Research on the Genotype-Phenotype Correspondence of Antibiotic Resistance in Helicobacter pylori and Its Molecular Mechanisms: A Narrative Review. | Gastroenterol Res Pract | 2026 | https://conductscience.org/library/papers/42935758 | PubMed |
| 42775880 | Carbon starvation of Mycobacterium abscessus induces a non-replicating state with extensive proteomic remodeling. | mSystems | 2026 | https://conductscience.org/library/papers/42775880 | PubMed |
| 41767945 | CRISPR-based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus. | mLife | 2026 | https://conductscience.org/library/papers/41767945 | PubMed |
| 41636541 | Mycobacterium abscessus research: learning from challenges. | J Bacteriol | 2026 | https://conductscience.org/library/papers/41636541 | PubMed |
| 41139833 | A Multiplexed, Target-Based Phenotypic Screening Platform Using CRISPR Interference in Mycobacterium abscessus. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/41139833 | PubMed |
| 41075152 | Evaluation of the interaction and synergy potential of bedaquiline and clarithromycin in combination with efflux pump inhibitors in clinical isolates of Mycobacterium abscessus complex. | Folia Microbiol (Praha) | 2025 | https://conductscience.org/library/papers/41075152 | PubMed |
| 41026774 | The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials. | Clin Infect Dis | 2026 | https://conductscience.org/library/papers/41026774 | PubMed |
| 40422286 | Limited predictive power of known resistance genes for phenotypic drug resistance in clinical Mycobacterium abscessus complex from Beijing in China. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40422286 | PubMed |
| 40332471 | Dual Mutations in MSMEG_0965 and MSMEG_1380 Confer High-Level Resistance to Bortezomib and Linezolid by Both Reducing Drug Intake and Increasing Efflux in Mycobacterium smegmatis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332471 | PubMed |
| 40177306 | Macrolide resistance in Mycobacterium abscessus: current insights and future perspectives. | JAC Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40177306 | PubMed |
| 40105336 | Subspecies distribution and drug-resistance characteristics of Mycobacterium abscessus complex clinical isolates in South China. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40105336 | PubMed |
| 39843836 | Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery. | NPJ Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39843836 | PubMed |
| 39599547 | Novel Synthetic Peptide Agelaia-12 Has Improved Activity Against Mycobacterium abscessus Complex. | Pathogens | 2024 | https://conductscience.org/library/papers/39599547 | PubMed |
| 39531471 | Biofilm formation and polar lipid biosynthesis in Mycobacterium abscessus are inhibited by naphthylmethylpiperazine. | PLoS One | 2024 | https://conductscience.org/library/papers/39531471 | PubMed |
| 39359892 | Transition metal homoeostasis is key to metabolism and drug tolerance of Mycobacterium abscessus. | NPJ Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39359892 | PubMed |
| 39021167 | Genomic Insights into Bacterial Antimicrobial Resistance Transmission and Mitigation Strategies. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/39021167 | PubMed |
| 38380095 | Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38380095 | PubMed |
| 38353553 | Lsr2, a pleiotropic regulator at the core of the infectious strategy of Mycobacterium abscessus. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38353553 | PubMed |
| 38266648 | Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria. | Cell Chem Biol | 2024 | https://conductscience.org/library/papers/38266648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32104016
GET https://conductscience.org/api/papers/v1/32104016/references?page=2